Cargando…

A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis

BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strai...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Ankit, Verma, Ajay Kumar, Kant, Surya, Prakash, Ved, Srivastava, Anand, Srivastava, Kanchan, Jain, Amita, Srivastava, Kishore K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592754/
https://www.ncbi.nlm.nih.gov/pubmed/28869227
http://dx.doi.org/10.4103/lungindia.lungindia_451_16
_version_ 1783262934663692288
author Kumar, Ankit
Verma, Ajay Kumar
Kant, Surya
Prakash, Ved
Srivastava, Anand
Srivastava, Kanchan
Jain, Amita
Srivastava, Kishore K
author_facet Kumar, Ankit
Verma, Ajay Kumar
Kant, Surya
Prakash, Ved
Srivastava, Anand
Srivastava, Kanchan
Jain, Amita
Srivastava, Kishore K
author_sort Kumar, Ankit
collection PubMed
description BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strains among MDR patients of pulmonary TB in Lucknow and surrounding areas. MATERIALS AND METHODS: It was a hospital-based epidemiological study. Our study population was selected from all the newly diagnosed patients attending outpatient department and admitted patients of Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India. Those isolates which were characterized to be MTB by morphological and molecular techniques were tested for their resistance against the first-line drugs; after which each patient's isolate was genotyped. RESULTS: The results suggested that the presence of Beijing genotype in 31.78% of strains. CONCLUSION: Our results predicted that genotypic patterns reveal a large diversity among the MTB Beijing strain population. Increasing frequency of Beijing strains demands further research to unravel the factors behind its propensity to prevail.
format Online
Article
Text
id pubmed-5592754
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55927542017-09-19 A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis Kumar, Ankit Verma, Ajay Kumar Kant, Surya Prakash, Ved Srivastava, Anand Srivastava, Kanchan Jain, Amita Srivastava, Kishore K Lung India Original Article BACKGROUND: Mycobacterium tuberculosis (MTB) Beijing strains are spread worldwide and are responsible for major outbreaks of tuberculosis (TB), sometimes spreading multidrug resistance (MDR). AIM: The aim of this study was to explore clinical features associated with the infection with Beijing strains among MDR patients of pulmonary TB in Lucknow and surrounding areas. MATERIALS AND METHODS: It was a hospital-based epidemiological study. Our study population was selected from all the newly diagnosed patients attending outpatient department and admitted patients of Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India. Those isolates which were characterized to be MTB by morphological and molecular techniques were tested for their resistance against the first-line drugs; after which each patient's isolate was genotyped. RESULTS: The results suggested that the presence of Beijing genotype in 31.78% of strains. CONCLUSION: Our results predicted that genotypic patterns reveal a large diversity among the MTB Beijing strain population. Increasing frequency of Beijing strains demands further research to unravel the factors behind its propensity to prevail. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5592754/ /pubmed/28869227 http://dx.doi.org/10.4103/lungindia.lungindia_451_16 Text en Copyright: © 2017 Indian Chest Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kumar, Ankit
Verma, Ajay Kumar
Kant, Surya
Prakash, Ved
Srivastava, Anand
Srivastava, Kanchan
Jain, Amita
Srivastava, Kishore K
A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title_full A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title_fullStr A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title_full_unstemmed A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title_short A study on Beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
title_sort study on beijing genotype in the clinical isolates of pulmonary drug-resistant tuberculosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592754/
https://www.ncbi.nlm.nih.gov/pubmed/28869227
http://dx.doi.org/10.4103/lungindia.lungindia_451_16
work_keys_str_mv AT kumarankit astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT vermaajaykumar astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT kantsurya astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT prakashved astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavaanand astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavakanchan astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT jainamita astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavakishorek astudyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT kumarankit studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT vermaajaykumar studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT kantsurya studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT prakashved studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavaanand studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavakanchan studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT jainamita studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis
AT srivastavakishorek studyonbeijinggenotypeintheclinicalisolatesofpulmonarydrugresistanttuberculosis